Mibampator is primarily researched for its potential therapeutic applications in neurological disorders. It functions as an AMPA receptor potentiator, which may enhance synaptic transmission and plasticity in the brain. This mechanism makes it a candidate for treating conditions like depression, cognitive impairment, and neurodegenerative diseases such as Alzheimer's. Early studies suggest it could improve memory and learning by modulating glutamate signaling, a key neurotransmitter involved in brain function. However, its clinical use is still under investigation, and further research is needed to confirm its efficacy and safety in humans.